Vivaldis Pimoben 5/10mg is a prescription-only, dual-action veterinary cardiovascular medication meticulously formulated to manage congestive heart failure (CHF) in medium and large breed dogs. It introduces a fixed-dose synergetic combination of two powerful cardiac agents: Pimobendan (5mg) and Benazepril Hydrochloride (10mg).

Pimobendan operates as a positive inotrope and calcium sensitizer, enhancing the efficiency of heart muscle contractions to optimize cardiac output. Concurrently, Benazepril works as an Angiotensin-Converting Enzyme (ACE) inhibitor, targeting the renin-angiotensin-aldosterone system (RAAS) to dilate blood vessels, lower system pressure, and combat harmful fluid buildup and cardiac remodeling. Together, this multi-pronged approach lowers peripheral resistance, minimizes cardiac workload, and treats debilitating clinical signs like coughing, lethargy, and fluid retention in the lungs. Administered orally on an empty stomach at strict 12-hour intervals, these palatable tablets significantly improve exercise tolerance and enhance long-term life expectancy.